Inventor · disambiguated record
Jan Tavernier
Also filed as: TAVERNIER JAN
63 granted patents·26 pending applications·467 citations·filing 1991–2025
99Inventor score
Files withVIB VZW36ORIONIS BIOSCIENCES INC23Orionis Biosciences BV16HOFFMANN LA ROCHE5VLAAMS INTERUNIV INST BIOTECH4
Top patents by PatentIndex Score
89 records- 0195US10640542B2Fusokines involving cytokines with strongly reduced receptor binding affinitiesVIB VZW·Filed 2014·Granted May 5, 2020·24 cites·6 claims
- 0295US10407480B2Targeted modified TNF family membersVIB VZW·Filed 2018·Granted Sep 10, 2019·17 cites·6 claims
- 0395US10035835B2Targeted modified TNF family membersVIB VZW·Filed 2018·Granted Jul 31, 2018·17 cites·12 claims
- 0495US10034919B2Targeted human-interferon fusion proteinsVIB VZW·Filed 2017·Granted Jul 31, 2018·20 cites·12 claims
- 0595US9878014B2Targeted human-interferon fusion proteinsVIB VZW·Filed 2016·Granted Jan 30, 2018·21 cites·12 claims
- 0694US11236166B2CD8 binding agentsOrionis Biosciences BV·Filed 2017·Granted Feb 1, 2022·10 cites·9 claims
- 0794US11001631B2Clec9A binding agentsOrionis Biosciences BV·Filed 2017·Granted May 11, 2021·12 cites·17 claims
- 0894US10946070B2Targeted and mutated human-interferon fusion proteinsVIB VZW·Filed 2018·Granted Mar 16, 2021·7 cites·12 claims
- 0994US10787493B2Targeted modified TNF family membersVIB VZW·Filed 2019·Granted Sep 29, 2020·6 cites·15 claims
- 1094US10072059B2Targeting of human interferon antagonistsVIB VZW·Filed 2017·Granted Sep 11, 2018·19 cites·5 claims
- 1193US10947288B2Targeting of human interferon antagonistsVIB VZW·Filed 2018·Granted Mar 16, 2021·6 cites·5 claims
- 1293US10906985B2Targeted engineered interferon and uses thereofORIONIS BIOSCIENCES INC·Filed 2018·Granted Feb 2, 2021·8 cites·16 claims
- 1393US9932409B2Targeted modified IL-1 family membersVIB VZW·Filed 2014·Granted Apr 3, 2018·18 cites·19 claims
- 1493US9914759B2Targeted modified TNF family membersVIB VZW·Filed 2014·Granted Mar 13, 2018·18 cites·13 claims
- 1593US9732135B2Targeting of human interferon antagonistsVIB VZW·Filed 2014·Granted Aug 15, 2017·23 cites·13 claims
- 1693US9492562B2Targeted human-interferon fusion proteinsVIB VZW·Filed 2013·Granted Nov 15, 2016·23 cites·4 claims
- 1792US11236141B2Targeted mutant interferon-beta and uses thereofOrionis Biosciences BV·Filed 2017·Granted Feb 1, 2022·7 cites·16 claims
- 1891US10988538B2Bispecific signaling agents and uses thereofOrionis Biosciences BV·Filed 2017·Granted Apr 27, 2021·9 cites·45 claims
- 1990US11440943B2Therapeutic interferon alpha 1 proteinsORIONIS BIOSCIENCES INC·Filed 2020·Granted Sep 13, 2022·2 cites·11 claims
- 2090US11246911B2Immune-cell targeted bispecific chimeric proteins and uses thereofVIB VZW·Filed 2018·Granted Feb 15, 2022·7 cites·14 claims
- 2189US11358997B2Fusokines involving cytokines with strongly reduced receptor binding affinitiesVIB VZW·Filed 2018·Granted Jun 14, 2022·3 cites·4 claims
- 2289US7575878B2Methods of inhibiting leptin-induced signaling with fibronectin III domain antibodiesVIB VZW·Filed 2005·Granted Aug 18, 2009·13 cites·3 claims
- 2388US11661455B2Chimeric protein comprising an interferon alpha 2mutant and a PD-L1 binding moietyOrionis Biosciences BV·Filed 2017·Granted May 30, 2023·4 cites·6 claims
- 2487US12473338B2Targeted engineered interferon and uses thereofORIONIS BIOSCIENCES INC·Filed 2020·Granted Nov 18, 2025·1 cites·6 claims
- 2587US11084859B2Targeted mutant interferon-gamma and uses thereofORIONIS BIOSCIENCES NV·Filed 2017·Granted Aug 10, 2021·6 cites·29 claims
- 2686US11384154B2Targeted chimeric proteins and uses thereofOrionis Biosciences BV·Filed 2018·Granted Jul 12, 2022·5 cites·12 claims
- 2785US11248057B2CD20 binding single domain antibodiesVIB VZW·Filed 2017·Granted Feb 15, 2022·3 cites·7 claims
- 2883US8048986B2Reversed mammalian protein-protein interaction trapVLAAMS INTERUNIV INST BIOTECH·Filed 2009·Granted Nov 1, 2011·4 cites·14 claims
- 2982US12227550B2Targeted modified TNF family membersVIB VZW·Filed 2022·Granted Feb 18, 2025·0 cites·7 claims
- 3082US8003757B2Receptor-based interaction trapVLAAMS INTERUNIV INST BIOTECH·Filed 2009·Granted Aug 23, 2011·4 cites·5 claims
- 3182US5652353ADNAs encoding tumor necrosis factor-α muteinsHOFFMANN LA ROCHE·Filed 1995·Granted Jul 29, 1997·38 cites·4 claims
- 3282US2023235086A1Targeted modified il-1 family membersVIB VZW·Filed 2023·Application pending·0 cites
- 3381US5422104ATNF-muteinsHOFFMANN LA ROCHE·Filed 1991·Granted Jun 6, 1995·46 cites·4 claims
- 3481US2025066486A1Clec9a binding agents and use thereofORIONIS BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 3580US12091463B2Clec9A binding agents comprising a recombinant heavy-chain only antibody (VHH)ORIONIS BIOSCIENCES INC·Filed 2018·Granted Sep 17, 2024·1 cites·8 claims
- 3680US2024360224A1Clec9a binding agents and use thereofORIONIS BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 3779US12364753B2CD8 binding agentsOrionis Biosciences BV·Filed 2021·Granted Jul 22, 2025·0 cites·16 claims
- 3879US12084497B2SIRP1α targeted chimeric proteins and uses thereofORIONIS BIOSCIENCES INC·Filed 2019·Granted Sep 10, 2024·1 cites·14 claims
- 3979US11753463B2Therapeutic targeting of non-cellular structuresOrionis Biosciences BV·Filed 2017·Granted Sep 12, 2023·2 cites·13 claims
- 4079US11498966B2PD-1 and PD-L1 binding agentsORIONIS BIOSCIENCES INC·Filed 2018·Granted Nov 15, 2022·1 cites·8 claims
- 4179US7423113B2Leptin antagonistVIB VZW·Filed 2004·Granted Sep 9, 2008·5 cites·2 claims
- 4279US5712121AChimeric interleukin 5-receptor/immunoglobulin polypeptidesHOFFMANN LA ROCHE·Filed 1995·Granted Jan 27, 1998·28 cites·27 claims
- 4378US11566072B2CD8 binding agentsORIONIS BIOSCIENCES INC·Filed 2018·Granted Jan 31, 2023·1 cites·22 claims
- 4478US2025361305A1Pd-1 and pd-l1 binding agentsORIONIS BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 4577US2025333463A1Targeted modified tnf family membersVIB VZW·Filed 2025·Application pending·0 cites
- 4676US12453770B2CLEC9A binding agentsOrionis Biosciences BV·Filed 2021·Granted Oct 28, 2025·0 cites·11 claims
- 4776US12410222B2Fusokines involving cytokines with strongly reduced receptor binding affinitiesVIB VZW·Filed 2022·Granted Sep 9, 2025·0 cites·2 claims
- 4876US12351633B2PD-1 and PD-L1 binding agentsORIONIS BIOSCIENCES INC·Filed 2022·Granted Jul 8, 2025·0 cites·16 claims
- 4976US11896643B2Fibroblast binding agents and use thereofORIONIS BIOSCIENCES INC·Filed 2019·Granted Feb 13, 2024·1 cites·11 claims
- 5075US10444245B2Trapping mammalian protein-protein complexes in virus-like particles utilizing HIV-1 GAG-bait fusion proteinsVIB VZW·Filed 2013·Granted Oct 15, 2019·1 cites·11 claims
Showing the top 50 of 89 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jan Tavernier files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →